🔎 Trials Near Me

Akèy › Maladi otoim › Minnesota › Rochester

Etid klinik pou Maladi otoim nan Rochester, MN

6 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3
  • Mayo Clinic - Accepting Adult Patients, Rochester
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Ap rekriteFaz 2
  • Mayo Clinic: Division of Rheumatology, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07103746

Abatacept for the Treatment of Giant Cell Arteritis

Ap rekriteFaz 3
  • Mayo Clinic, Rochester
Laj 50 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT04474847

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Ap rekriteFaz 2/3
  • Mayo Clinic Rochester, Rochester
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
  • Mayo Clinic - Rochester, Rochester
Laj 18 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT06359041

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Ap rekriteFaz 1
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT06626919

Etid Maladi otoim nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.